We are live on
!
Find out more
VOYA Investment Management Portfolio holdings
AUM
$116B
1-Year Est. Return
61.47%
This Fund
S&P 500
This Quarter
Est. Return
+18.35%
1 Year Est. Return
+61.47%
3 Year Est. Return
+172.42%
5 Year Est. Return
+231.94%
10 Year Est. Return
+892.64%
AUM
$49.3B
AUM Growth
+$4.17B
(+9.2%)
Cap. Flow
-$2.67B
Cap. Flow
% of AUM
-5.42%
Top 10 Holdings %
Top 10 Hldgs %
21.05%
Holding
2,729
New
233
Increased
1,401
Reduced
1,043
Closed
48
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$270M |
| 2 |
Qualcomm
QCOM
|
+$245M |
| 3 |
Expedia Group
EXPE
|
+$223M |
| 4 |
DexCom
DXCM
|
+$206M |
| 5 |
Eli Lilly
LLY
|
+$171M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$353M |
| 2 |
AbbVie
ABBV
|
+$340M |
| 3 |
Microsoft
MSFT
|
+$328M |
| 4 |
Cadence Design Systems
CDNS
|
+$280M |
| 5 |
Salesforce
CRM
|
+$252M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.71% |
| 2 | Healthcare | 13.97% |
| 3 | Consumer Discretionary | 13.18% |
| 4 | Financials | 11.29% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Zentalis Pharmaceuticals
ZNTL
$307M
| $621K | ﹤0.01% |
+11,949
| New | +$539K |
|
1777
Carlyle Group
CG
$17.5B
| $620K | ﹤0.01% |
19,722
-989
| -5% | -$27.9K |
|
1778
Enviri
NVRI
$583M
| $620K | ﹤0.01% |
34,474
+7,456
| +28% | +$120K |
|
1779
Griffon
GFF
$4.83B
| $618K | ﹤0.01% |
30,332
+5,742
| +23% | +$124K |
|
1780
Methode Electronics
MEI
$604M
| $617K | ﹤0.01% |
16,123
+3,490
| +28% | +$119K |
|
|
AUY
1781
DELISTED
Yamana Gold, Inc.
AUY
| $617K | ﹤0.01% |
108,033
+40,554
| +60% | +$228K |
|
|
EIDX
1782
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $617K | ﹤0.01% |
+4,687
| New | +$414K |
|
1783
Northwest Natural Holdings
NWN
$2.14B
| $616K | ﹤0.01% |
13,380
+655
| +5% | +$31K |
|
|
LSXMA
1784
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $616K | ﹤0.01% |
19,415
-1,838
| -9% | -$53.1K |
|
|
MRSN
1785
DELISTED
Mersana Therapeutics
MRSN
| $614K | ﹤0.01% |
922
+204
| +28% | +$113K |
|
1786
United Natural Foods
UNFI
$2.91B
| $614K | ﹤0.01% |
38,453
+3,670
| +11% | +$61.4K |
|
1787
Hawaiian Electric Industries
HE
$2.06B
| $610K | ﹤0.01% |
17,241
-2,710
| -14% | -$95.9K |
|
|
ARGO
1788
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $610K | ﹤0.01% |
13,955
+2,960
| +27% | +$118K |
|
1789
BJ's Restaurants
BJRI
$1.44B
| $607K | ﹤0.01% |
15,771
+2,746
| +21% | +$93.6K |
|
|
SPR
1790
DELISTED
Spirit AeroSystems
SPR
| $606K | ﹤0.01% |
15,498
-1,005
| -6% | -$28.8K |
|
1791
Inovio Pharmaceuticals
INO
$92.3M
| $605K | ﹤0.01% |
5,700
+1,269
| +29% | +$169K |
|
1792
Lindsay Corp
LNN
$1.16B
| $604K | ﹤0.01% |
4,698
-36,323
| -89% | -$4.14M |
|
1793
Ocular Therapeutix
OCUL
$2.24B
| $604K | ﹤0.01% |
29,200
+9,025
| +45% | +$134K |
|
1794
Carpenter Technology
CRS
$26.5B
| $603K | ﹤0.01% |
20,705
+4,763
| +30% | +$110K |
|
1795
St. Joe Company
JOE
$3.9B
| $601K | ﹤0.01% |
14,169
+2,495
| +21% | +$79.4K |
|
1796
Scansource
SCSC
$1.06B
| $601K | ﹤0.01% |
22,776
+1,912
| +9% | +$45.9K |
|
1797
Travere Therapeutics
TVTX
$5.78B
| $600K | ﹤0.01% |
22,030
+6,620
| +43% | +$155K |
|
|
ZUO
1798
DELISTED
Zuora, Inc.
ZUO
| $600K | ﹤0.01% |
43,062
+9,307
| +28% | +$106K |
|
|
CVGW
1799
DELISTED
Calavo Growers
CVGW
| $599K | ﹤0.01% |
8,626
-1,472
| -15% | -$104K |
|
1800
Hexcel
HXL
$7.64B
| $598K | ﹤0.01% |
12,323
-799
| -6% | -$34.8K |
|
Similar funds
VAM
VOYA Investment Management's Q4 2020 Portfolio in Review
As of Q4 2020, VOYA Investment Management held 2,729 positions worth $49.3B, up 9.2% from $45.2B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
VOYA Investment Management withdrew a net $2.67B in Q4 2020, closing 48 positions and reducing 1,043 holdings. Its most notable exit was Novartis, an estimated $54.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, VOYA Investment Management opened a new position in Concentrix worth $14M.
- VOYA Investment Management's largest Q4 2020 buy was Concentrix: 141,626 shares worth $14M.
- VOYA Investment Management added most to PayPal in Q4 2020, an estimated $270M increase.
- VOYA Investment Management's biggest Q4 2020 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $353M.
- VOYA Investment Management fully exited Novartis in Q4 2020, selling an estimated $54.3M.
- VOYA Investment Management's ten largest holdings make up 21% of its $49.3B portfolio in Q4 2020.
- VOYA Investment Management opened 233 new positions and closed 48 in Q4 2020.
- VOYA Investment Management's portfolio value rose 9.2% quarter-over-quarter to $49.3B.
Based on VOYA Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.